SUBSCRIBERS
US researchers using nanotech, gene editing to turn off cholesterol gene in mice
Published Tue, Nov 14, 2017 · 09:50 PM
Chicago
RESEARCHERS in the US have used nanotechnology plus the powerful CRISPR-Cas9 gene editing tool to turn off a key cholesterol-related gene in mouse liver cells, an advance that could lead to new ways to correct genes that cause high cholesterol and other liver diseases.
Nanotechnology is the design and manipulation of materials thousands of times smaller than the width of a human hair.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Technology
Apple scores win in labor case involving fired retail workers
Brokers’ take: DBS cuts Venture Corp price target after Q1 earnings miss
Garmin’s Q1 results beat on strong demand for fitness, auto products
Foxconn’s musical chairs sound like punk rock
US sets up board to advise on safe, secure use of AI
Regulate AI? How US, EU and China are going about It